Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Deepak Kilari, Aniko Szabo, Pooja Ghatalia, Tracy L Rose, Huaying Dong, Nicole Weise, Tony Z. Zhuang, Abdurahman Alloghbi, Rohit K. Jain, Ajjai Shivaram Alva, Abhishek Tripathi, Arnab Basu, Nancy B. Davis, James Brundage, Hamid Emamekhoo, Yousef Zakharia, Vadim S Koshkin, Mehmet Asim Bilen, Elisabeth I. Heath, Rana R. McKay
Institutions: Medical College of Wisconsin, Fox Chase Cancer Center, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Moores Cancer Center, Emory University, Wayne State University, The Barbara Ann Karmanos Cancer Institute, Moffitt Cancer Center, University of Michigan, U-M Rogel Cancer Center, OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of Alabama at Birmingham, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Huntsman Cancer Institute, University of Wisconsin–Madison, University of Iowa, University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Diego
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4286293551